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Generalized vitiligo is a common autoimmune disorder characterized by the development of white patches of skin
and overlying hair due to loss of pigment-forming melanocytes from the involved areas. Family clustering of cases
is not uncommon, in a pattern suggestive of multifactorial, polygenic inheritance, and there is strong association
between vitiligo and other autoimmune diseases. To map genetic loci that confer susceptibility to generalized vitiligo
and perhaps other autoimmune diseases, we performed a genomewide linkage scan in 71 white multiplex families
with vitiligo from North America and the United Kingdom. Linkage was assessed by multipoint nonparametric
linkage analyses. One linkage signal, AIS1, located at 1p31, met genomewide criteria for highly significant linkage
(nonparametric LOD 5.56; ), establishing its importance as a major vitiligo susceptibility locus.Pp .000000282
An additional seven signals, on chromosomes 1, 7, 8, 11, 19, and 22, met genomewide criteria for “suggestive
linkage,” and will thus be of particular importance for follow-up studies.
Generalized vitiligo (MIM193200) is a common acquired
autoimmune disorder characterized by development of
white patches of skin, overlying hair, and oral mucosa
due to loss of melanocytes from the involved areas. Be-
cause of its striking appearance, vitiligo has been known
for at least 3,500 years (Nair 1978), although even today
relatively little is known of its pathogenesis (Bolognia et
al. 1998; Kovacs 1998; Hann and Nordlund 2000).Most
cases appear to result from a noninflammatory, T cell
autoimmune response against melanocytes (Ongenae et
al. 2003). Generalized vitiligo is associated with other
autoimmune disorders in ∼23% of cases, particularly
autoimmune thyroid disease, pernicious anemia, sys-
temic lupus erythematosus, and Addison disease (Alk-
hateeb et al. 2003), and vitiligo is an occasional com-
ponent of autoimmune polyendocrinopathy syndrome
type 1 (APS1) (Neufield et al. 1980; Perheentupa 1996).
Several lines of evidence support a genetic component
Received January 17, 2003; accepted for publication March 11,
2003; electronically published April 18, 2003.
Address for correspondence and reprints: Dr. Richard A. Spritz,
Professor and Director, Human Medical Genetics Program, University
of Colorado Health Science Center, Box B161, 4200 East Ninth Avenue,
Denver, CO 80262. E-mail address: Richard.Spritz@UCHSC.edu
 2003 by The American Society of Human Genetics. All rights reserved.
0002-9297/2003/7206-0020$15.00
in generalized vitiligo. The disease occurswith a frequency
of 0.1%–2% in various populations (Bolognia et al.
1998; Hann and Nordlund 2000), but it is much more
frequent among probands’ relatives: 7.0%among all first-
degree relatives, 6.1% among siblings, and 23% among
MZ twins (Alkhateeb et al. 2003). Family clustering of
cases (Mehta et al. 1973; Carnevale et al. 1980; Goudie
et al. 1983; Hafez et al. 1983; Das et al. 1985;Majumder
et al. 1993) and segregation analyses (Majumder et al.
1988; Nath et al. 1994) have suggested the involvement
of multiple interacting genes in different populations,
as well as nongenetic factors.
A number of candidate genes have been suggested to
mediate susceptibility to vitiligo, including AIRE (Finn-
ish-German APECED Consortium 1997; Nagamine et al.
1997), CTLA4 (Kemp et al. 1999),GCH1 (de la Fuente-
Fernandes 1997; Bandyopadhyay et al. 2000), VIT1 (Le
Poole et al. 2001), the major histocompatibility complex
(MHC) (Orecchia et al. 1992; Zamani et al. 2001; Ar-
cos-Burgos et al. 2002), CAT (Casp et al. 2002), COMT
(Tursen et al. 2002), and SLEV1 (Nath et al. 2001). In
addition, elsewhere, we reported highly suggestive link-
age between vitiligo and a locus in chromosome segment
1p31.3–p32.2, termed “AIS1,” in a single large white
family (Alkhateeb et al. 2002).
Here, we describe a genomewide genetic linkage analy-
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Table 1
Composition of 71 Multiplex White Vitiligo
Study Families










Affected sib pair 32
a Studied elsewhere (Alkhateeb et al. 2002).
sis of 70 additional white families with generalized vit-
iligo from the United States and the United Kingdom.
Our results strongly confirm AIS1 as a major locus for
vitiligo susceptibility. We also detect seven additional
suggestive linkage signals that may represent other genes
involved in the pathogenesis of vitiligo and perhaps also
other autoimmune disorders associated with vitiligo.
Identification of these genes may thus shed light on the
pathogenic mechanisms underlying these specific disor-
ders, as well as susceptibility to autoimmune disorders
in general.
Families were recruited principally from the Vitiligo
Society (U.K.) and the National Vitiligo Society (U.S.A.)
by mailing an ascertainment questionnaire to the entire
memberships of these two organizations. Inclusioncriteria
were specified as acquired patchy depigmentation with
typical distribution (principally, face, hands, and genital
area). Exclusion criteria included atypical lesion distri-
bution, congenital (birthmarks, piebaldism, Waarden-
burg syndrome, etc.) or static depigmentation, and de-
pigmentation due to use of melanocytotoxic chemicals,
inflammatory skin diseases (lupus, lichen planus, or pso-
riasis), and postinfectious or posttraumatic causes. Phe-
notypes were checked carefully by history, lesion maps,
and, in most cases, physical examination and/or pho-
tographs; individuals in whom the phenotype was at all
questionable were also excluded.
We collected peripheral blood samples from 71 families
(table 1) and extracted DNA by standard methods. Ge-
notyping was carried out for 382 autosomal microsat-
ellite markers from ABI Prism Linkage Mapping Set
LMSv2-MD10, distributed at ∼10-cM intervals. X- and
Y-chromosomal markers were not typed, owing to the
equal sex distribution of vitiligo and the frequent oc-
currence of male-to-male transmission. PCRs were set
up and pooled by use of an MWG robotic thermocycler,
and reaction products were detected on ABI 377 se-
quencers. Marker data were analyzed using Genescan
3.1 and Genotyper 2.5, with manual checking of all
genotypes by at least two people to minimize data errors.
Mendelian inheritance of marker alleles was checked
manually within Genotyper and through all levels of
PedCheck (O’Connell and Weeks 1998). In selected in-
dividuals from families showing linkage to chromosome
1p, we genotyped up to 49 additional 1p markers to
increase linkage information.
Multipoint parametric and nonparametric linkage
analyses were performed using Genehunter 2.1 (Krug-
lyak et al. 1996) and Allegro (Gudbjartsson et al. 2000).
Parametric LOD analyses were performed under both
dominant and recessive models using the affecteds-only-
plus-founders approach, by use by allele frequency and
penetrance ratios consistent with the disease prevalence
for vitiligo in whites of 0.5% (Howitz et al. 1977). Non-
parametric LOD scores and corresponding P values were
calculated according to Kong and Cox (1997), using an
exponential model and equal family weighting under
both Spairs and Sall scoring functions, with five interval
steps between each marker. Spairs performs well over all
disease models in affected sib pairs (McPeek 1999),
whereas Sall performs well under a dominant model and
is perhaps more suitable for extended families (Kruglyak
et al. 1996).
Elsewhere, we reported genomewide linkage analysis
of a single large kindred in which we found highly sug-
gestive linkage between generalized vitiligo and suscep-
tibility to Hashimoto disease and a locus we termed
“AIS1,” located in an ∼14.4-cM interval between
D1S2742 and D1S515 in chromosome 1p31.3-p32.2. In
this family, linkage maximized under a dominant model
with penetrance 0.5 (Alkhateeb et al. 2002). In the pre-
sent study of 70 new families, we found a nonparametric
LODall of 3.17 ( ) at 73 cM, within thePp .0000538
AIS1 genetic interval, strongly confirming AIS1 as a ma-
jor locus for vitiligo. When the 70 new families were
analyzed in combination with the previous family, we
obtained a summary nonparametric LOD score of 5.56
( ) at 82 cM, also within the AIS1 in-Pp .000000282
terval. The dominant heterogeneity LOD (HLOD) at this
position was 4.77 with . It is interesting thatap 0.35
the recessive HLOD also achieved a maximum within
the AIS1 interval, 2.21 ( ) at 71 cM. These sum-ap 0.37
mary data achieve genomewide criteria for highly sig-
nificant linkage (Terwilliger and Ott 1994; Lander and
Kruglyak 1995; Nyholt 2000), providing robust con-
firmation of AIS1 as a vitiligo susceptibility locus that
contributes to vitiligo in about one-third of multiplex
families, possibly involving both dominant- and re-
cessive-acting alleles.
Besides AIS1, we detected seven additional nonpara-
metric linkage signals that met genomewide threshold
criteria for “suggestive linkage” (LOD 1.86 or P 
; Lander and Kruglyak 1995; Nyholt 2000) (table.0017
2) on chromosomes 1, 7, 8, 11, 16, 19, and 22; the
signal in the telomeric region of chromosome 1p appears
to be distinct fromAIS1. These suggestive linkage signals
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Table 2
Significant and Suggestive Genomewide Multipoint Nonparametric LODs






1 15–16 2.17 ( )Pp .000335 2.11 ( 0)Pp .00092
82c 5.56 ( )Pp .000000282 2.17 ( 1)Pp .00078
7 79–93 2.87 ( )Pp .000131 1.85 ( )Pp .00173
8 68 1.95 ( )Pp .00135
11 11–15 1.34 ( )Pp .00167 1.93 ( )Pp .00142
19 33–34 1.41 ( )Pp .00145 2.45 ( )Pp .000388
102 2.31 ( )Pp .000553
22 23–24 2.30 (Pp .000561)
NOTE.—Only signals achieving “significant” ( and/orLOD  3.3 P 
) or “suggestive” ( and/or ) linkage thresholds.000049 LOD 1.86 P  .0017
(Terwilliger and Ott 1994; Lander and Kruglyak 1995; Nyholt 2000) are
reported.
a Corresponding to Sall scoring function.
b Corresponding to Spairs scoring function.
c AIS1.
Table 3






AIS1 1p31.3–p32.2 (∼82) 5.56 (Pp .000000282 2.17 (Pp .000781
VIT1 2p16 (∼72) .29 ( )Pp .11 .45 ( )Pp .08
CTLA4 2q33 (∼194) .04 ( )Pp .32 .01 ( )Pp .43
MITF 3p14.1–p12.3 (∼95) .13 ( )Pp .21 .19 ( )Pp .17
MHC 6p21.3 (∼51–53) .04 ( )Pp .33 .01 ( )Pp .42
CAT 11p13 (∼48) .30 ( )Pp .11 .27 ( )Pp .13
GCH1 14q22.1–q22.2 (∼53) .06 ( )Pp .30 .06 ( )Pp .30
SLEV1 17p (∼10–28) .48 ( )Pp .05 .75 ( )Pp .03
AIRE 21q22.3 (∼52) .45 ( )Pp .06 .38 ( )Pp .09
COMT 22q11.21 (∼17) .92 ( )Pp .01 1.88 ( )cPp .002
a Corresponding to Sall scoring function.
b Corresponding to Spairs scoring function.
c A LODpairs score of 2.30 ( ) was achieved at 23–24 cM on chromosome 22.Pp .000561
thus represent candidates for confirmation by future ex-
tension and replication studies.
The ∼14.4-cM AIS1 genetic interval corresponds to
only ∼7.4 Mb and contains 24 known genes, 26 pre-
dicted genes or gene segments, and 5 predicted pseu-
dogenes. Although there is no mouse model for vitiligo,
the mouse white-spotting mutant, misty (m), maps to
∼46.1 cM on mouse chromosome 4, in a segment ho-
mologous to the human AIS1 interval (unpublished
data), suggesting the possibility that mouse misty might
be homologous to human AIS1. AIS1 appears to act
principally as a dominant, although perhaps also with
some recessive alleles, whereas misty is recessive but
characterized by highly variable phenotypic expressivity
and incomplete penetrance, depending on genetic back-
ground (Woolley 1941, 1945), and we note that a num-
ber of loci are known in which dominant and recessive
alleles result in similar phenotypes. It also is of interest
that the AIS1 interval is contained within the interval
for PSOR7, a locus associated with susceptibility to pso-
riasis (Veal et al. 2001), suggesting the possibility that
these two loci might be identical. However, the preva-
lence of psoriasis is not significantly elevated among pa-
tients with vitiligo (Alkhateeb et al. 2003), indicating
that this is unlikely.
The locations of neither AIS1 nor the seven additional
suggestive vitiligo linkage signals we observed correspond
to the locations of most of the candidate genes suggested
for vitiligo, including VIT1, CTLA4, MITF, the MHC,
CAT, GCH1, and SLEV1 (table 3). However, we ob-
tained a nonparametric LODpairs score of 2.30 (Pp
) ∼6 cM proximal to the position of COMT in.000561
22q11.2, for which there is marginal association with
acrofacial vitiligo, although not with generalized vitiligo
(Tursen et al. 2002). Our results do not definitively sup-
port involvement of any of these candidate genes in the
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pathogenesis of generalized vitiligo in multiplex families,
although our findings may or may not be relevant to
singleton patients who comprise the majority of cases.
Finally, we considered whether the linkage signals we
detected for vitiligo correspond to any of the regions of
linkage or association reported for the principal au-
toimmune disorders that are highly associated with vit-
iligo (Alkhateeb et al. 2003). Of the total 20 genomic
regions showing linkage or association with autoimmune
thyroid disease (Sakai et al. 2001; Vaidya et al. 2002),
pernicious anemia (Thompsen et al. 1981), Addison dis-
ease (Weetman et al. 1991; Vaidya et al. 2000), or lupus
(Moser et al. 1998; Kelly et al. 2002), none corresponded
to the linkage signals we detected for vitiligo (not
shown). These results suggest that, in general, the loci
that determine general susceptibility to the vitiligo-as-
sociated constellation of autoimmune disorders may be
different from those that determine susceptibility to the
individual component autoimmune diseases themselves.
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